FDA DEVICE FACTS
Panta 2 Arthrodesis Nail System
Integra LifeSciences Corporation
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
The Panta 2 Arthrodesis Nail System is intended for use in tibiotalocalcaneal arthrodesis and treatment of trauma to the hindfoot and distal tibia. Indications include:
• Post-traumatic and degenerative arthritis involving both ankle and subtalar joints
• Rheumatoid arthritis
• Revision of failed ankle arthrodesis with subtalar involvement or with insufficient talar body
• Revision of failed total ankle arthroplasty with subtalar intrusion
• Talar deficiency conditions (requiring a tibiocalcaneal arthrodesis)
• Avascular necrosis of the talus
• Neuroarthropathy or neuropathic ankle deformity
• Severe deformity as a result of talipes equinovarus, cerebral vascular accident, paralysis or other neuromuscular disease
• Severe pilon fractures with trauma to the subtalar joint. Nonclinical
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。